Co-Authors
This is a "connection" page, showing publications co-authored by Gianfranco Sinagra and Piergiuseppe Agostoni.
Connection Strength
2.516
-
The prognostic value of serial troponin measurements in patients admitted for COVID-19. ESC Heart Fail. 2021 10; 8(5):3504-3511.
Score: 0.239
-
Ghrelin Derangements in Idiopathic Dilated Cardiomyopathy: Impact of Myocardial Disease Duration and Left Ventricular Ejection Fraction. J Clin Med. 2019 Aug 01; 8(8).
Score: 0.209
-
Do rebreathing manoeuvres for non-invasive measurement of cardiac output during maximum exercise test alter the main cardiopulmonary parameters? Eur J Prev Cardiol. 2019 10; 26(15):1616-1622.
Score: 0.205
-
Anaerobic Threshold and Respiratory Compensation Point Identification During Cardiopulmonary Exercise Tests in Chronic Heart Failure. Chest. 2019 08; 156(2):338-347.
Score: 0.204
-
Isocapnic buffering period: From physiology to clinics. Eur J Prev Cardiol. 2019 07; 26(10):1107-1114.
Score: 0.202
-
Multiparametric prognostic scores in chronic heart failure with reduced ejection fraction: a long-term comparison. Eur J Heart Fail. 2018 04; 20(4):700-710.
Score: 0.184
-
Interleukin-1ß levels predict long-term mortality and need for heart transplantation in ambulatory patients affected by idiopathic dilated cardiomyopathy. Oncotarget. 2017 Apr 11; 8(15):25131-25140.
Score: 0.178
-
Left ventricular function and exercise performance in idiopathic dilated cardiomyopathy: role of tissue Doppler imaging. J Cardiovasc Med (Hagerstown). 2017 Apr; 18(4):230-236.
Score: 0.178
-
Prognostic role of ß-blocker selectivity and dosage regimens in heart failure patients. Insights from the MECKI score database. Eur J Heart Fail. 2017 07; 19(7):904-914.
Score: 0.176
-
Reference Values for Peak Exercise Cardiac Output in Healthy Individuals. Chest. 2017 06; 151(6):1329-1337.
Score: 0.175
-
Metabolic exercise test data combined with cardiac and kidney indexes, the MECKI score: a multiparametric approach to heart failure prognosis. Int J Cardiol. 2013 Sep 10; 167(6):2710-8.
Score: 0.128
-
Implications of atrial fibrillation on the clinical course and outcomes of hospitalized COVID-19 patients: results of the Cardio-COVID-Italy multicentre study. Europace. 2021 10 09; 23(10):1603-1611.
Score: 0.061
-
Determinants of the protective effect of glucocorticoids on mortality in hospitalized patients with COVID-19: Insights from the Cardio-COVID-Italy multicenter study. Int J Infect Dis. 2021 Jul; 108:270-273.
Score: 0.059
-
Impact of heart failure on the clinical course and outcomes of patients hospitalized for COVID-19. Results of the Cardio-COVID-Italy multicentre study. Eur J Heart Fail. 2020 12; 22(12):2238-2247.
Score: 0.057
-
Pulmonary embolism in patients with COVID-19: characteristics and outcomes in the Cardio-COVID Italy multicenter study. Clin Res Cardiol. 2021 Jul; 110(7):1020-1028.
Score: 0.057
-
Association of Troponin Levels With Mortality in Italian Patients Hospitalized With Coronavirus Disease 2019: Results of a Multicenter Study. JAMA Cardiol. 2020 Nov 01; 5(11):1274-1280.
Score: 0.057
-
Heart failure prognosis over time: how the prognostic role of oxygen consumption and ventilatory efficiency during exercise has changed in the last 20 years. Eur J Heart Fail. 2019 02; 21(2):208-217.
Score: 0.050
-
Dose-dependent efficacy of ß-blocker in patients with chronic heart failure and atrial fibrillation. Int J Cardiol. 2018 Dec 15; 273:141-146.
Score: 0.049
-
Clinical and prognostic impact of chronotropic incompetence in patients with hypertrophic cardiomyopathy. Int J Cardiol. 2018 Nov 15; 271:125-131.
Score: 0.049